Fundraising Fox
Vesteck</a> (Copy)
West Chester, US · Founded 2019 · Delaware corporation · 4 known investors
Find your way into Vesteck</a> (Copy)
Sign up to see every warm intro you have to Vesteck</a> (Copy)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vesteck</a> (Copy) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vesteck develops medical device technology in the cardiovascular/endovascular space. The investors page presents an investor presentation and a section on the company's backers but does not name specific individuals or firms.
Founders & leadership
Vesteck</a> (Copy) was founded in 2019 by JOSEPH W. RAFFERTY.
JW
JOSEPH W. RAFFERTYFounderJoseph W. Rafferty is an executive officer and director at Vesteck, a medical device company developing cardiovascular and endovascular technologies. He has experience in commercialization, operations, product launch, regulatory affairs, and sales in interventional cardiology and related specialty markets.
RJ
Rafferty JosephExecutiveRafferty Joseph is Executive Officer and Director at Vesteck, a medical device company focused on cardiovascular and endovascular technologies. His background spans commercialization, operations, sales, and product development in interventional cardiology and related medical specialties.
EW
Edward WulfmanExecutive
JE
John EdogaNamed on SEC filing
JD
JOHN DIEDERICHNamed on SEC filing
TR
THIERRY RICHARDNamed on SEC filing
RM
ROBERT MITCHELLNamed on SEC filing
KS
Kent StalkerPrincipal Investigator
Board
BP
Benjamin PatzBoard director
JD
John DiedrichBoard director
SO
Stephen O'HaraBoard director
Investors · 4
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · Not right? Tell us
New World Angelslisted by New World AngelsBoca Raton
How we know: New World Angels's portfolio page · Not right? Tell us
Ocean Azul Partnerslisted by Ocean Azul PartnersCoral Gables · $500K – $2M
How we know: Ocean Azul Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$7M disclosed across 3 rounds · 2021–2025
▶$353.6KraisedOct 2025 · 15 investors · Other TechnologyRule 506(b)
▶$353.6KraisedOct 2025 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin PatzDirector
- John DiedrichDirector
- John EdogaDirector
- Rafferty JosephExecutive Officer, Director
- Stephen O'HaraDirector
- Kent StalkerExecutive Officer
- Edward WulfmanExecutive Officer
- Offering amount
- $500K
- Amount sold
- $353.6K
- Proceeds to insiders
- $200K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedJan 2023 · 30 investors · Other Health CareRule 506(b)
▶$2.3MraisedJan 2023 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JOSEPH W. RAFFERTYExecutive Officer, Director
- JOHN EDOGADirector
- ROBERT MITCHELLDirector
- JOHN DIEDERICHDirector
- KEN RUBENSTEINDirector
- THIERRY RICHARDDirector
- SAIM MERT OZYUREKDirector
- Offering amount
- $4M
- Amount sold
- $2.3M
- Proceeds to insiders
- $300K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$4.4MraisedSep 2021 · 38 investors · Other Health CareRule 506(b)
▶$4.4MraisedSep 2021 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JOHN DIEDERICHDirector
- THIERRY RICHARDDirector
- JOHN EDOGADirector
- ROBERT MITCHELLDirector
- JOSEPH W. RAFFERTYExecutive Officer, Director, Promoter
- Offering amount
- $6M
- Amount sold
- $4.4M
- Proceeds to insiders
- $300K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies working in the same space as Vesteck</a> (Copy).
Frequently asked questions
- What does Vesteck</a> (Copy) do?
- Vesteck develops medical device technology in the cardiovascular/endovascular space. The investors page presents an investor presentation and a section on the company's backers but does not name specific individuals or firms.
- Who founded Vesteck</a> (Copy)?
- Vesteck</a> (Copy) was founded by JOSEPH W. RAFFERTY in 2019.
- Who are Vesteck</a> (Copy)'s investors?
- Vesteck</a> (Copy)'s investors include BioAdvance, New World Angels, Ocean Azul Partners, Robin Hood Ventures.
- How much funding has Vesteck</a> (Copy) raised?
- Vesteck</a> (Copy) has disclosed $7M raised across 3 rounds.
- Where is Vesteck</a> (Copy) headquartered?
- Vesteck</a> (Copy) is headquartered in West Chester, US.